مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

205
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

108
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

UROLOGICAL ONCOLOGY: The Effect of Phosphodiesterase 5 Inhibitor on Biochemical Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer

Pages

  255-259

Abstract

 Purpose: Recently, controversy exists regarding the oncologic outcomes associated with the use of phosphodiesterase 5 inhibitor (PDE5i). Therefore, we attempted to verify the effect of PDE5i on biochemical recurrence (BCR) following radical prostatectomy (RP) in patients with prostate cancer (PCa). Materials and Methods: From January 2011 to May 2016, 351 patients who had undergone bilateral neurovascular bundle saving and who were confirmed as having pT2N0M0 disease were included in the present study. We divided these patients into three groups: no PDE5i use, PDE5i use on demand, and PDE5i use for rehabilitation. We retrospectively analyzed the effect of PDE5i on BCR of PCa. Mean follow-up period was 34. 4 months and mesurement of outcome was whether the patients developed BCR during regular follow-up. Results: 25 (7. 1%) patients showed BCR and univariate analysis found no significant differences in BCR between the three groups (5 (6. 9%) in no PDE5i use, 8 (9. 5%) in PDE5i use on demand, 12 (6. 2%) in PDE5i use for rehabilitation). Multivariable analyses showed that treatment type was not a significant factor for BCR between the groups with no PDE5i use and PDE5i use (HR = 1. 34 [0. 49– 3. 70]; P =. 573) and between the groups with on demand and rehabilitation use (HR = 1. 37 [0. 35– 5. 37]; P =. 646). Kaplan-Meier survival curves show that there were no significant differences in PSA recurrence-free survival in three groups (P >. 05). Conclusion: Use of PDE5is was not associated with any adverse effects on BCR after RP in patients with PCa.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Chung, Jae Wook, Kim, Jin Woo, Ha, Yun Sok, Choi, Seock Hwan, Lee, Jun Nyung, Kim, Bum Soo, Kim, Hyun Tae, Yoo, Eun Sang, Kwon, Tae Gyun, & Kim, Tae Hwan. (2019). UROLOGICAL ONCOLOGY: The Effect of Phosphodiesterase 5 Inhibitor on Biochemical Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer. UROLOGY JOURNAL, 16(3), 255-259. SID. https://sid.ir/paper/271557/en

    Vancouver: Copy

    Chung Jae Wook, Kim Jin Woo, Ha Yun Sok, Choi Seock Hwan, Lee Jun Nyung, Kim Bum Soo, Kim Hyun Tae, Yoo Eun Sang, Kwon Tae Gyun, Kim Tae Hwan. UROLOGICAL ONCOLOGY: The Effect of Phosphodiesterase 5 Inhibitor on Biochemical Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer. UROLOGY JOURNAL[Internet]. 2019;16(3):255-259. Available from: https://sid.ir/paper/271557/en

    IEEE: Copy

    Jae Wook Chung, Jin Woo Kim, Yun Sok Ha, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, and Tae Hwan Kim, “UROLOGICAL ONCOLOGY: The Effect of Phosphodiesterase 5 Inhibitor on Biochemical Recurrence Following Radical Prostatectomy in Patients with Prostate Cancer,” UROLOGY JOURNAL, vol. 16, no. 3, pp. 255–259, 2019, [Online]. Available: https://sid.ir/paper/271557/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button